L&K Biomed Ltd. (KOSDAQ: 156100)
South Korea
· Delayed Price · Currency is KRW 6,680.00
-220.00 (-3.19%)
Dec 20, 2024, 2:56 PM KST
L&K Biomed Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 33,184 | 29,905 | 19,767 | 15,373 | 19,356 | 26,575 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | -0 | - | 0 | Upgrade
|
| Revenue | 33,184 | 29,905 | 19,767 | 15,373 | 19,356 | 26,575 | Upgrade
|
| Revenue Growth (YoY) | 17.56% | 51.28% | 28.59% | -20.58% | -27.16% | -15.16% | Upgrade
|
| Cost of Revenue | 4,528 | 4,227 | 4,975 | 8,019 | 5,899 | 13,932 | Upgrade
|
| Gross Profit | 28,656 | 25,678 | 14,792 | 7,354 | 13,457 | 12,643 | Upgrade
|
| Selling, General & Admin | 21,968 | 20,967 | 24,261 | 19,647 | 13,696 | 14,842 | Upgrade
|
| Research & Development | 1,661 | 1,329 | 1,369 | 1,358 | 977.97 | 1,915 | Upgrade
|
| Operating Expenses | 26,309 | 23,644 | 27,530 | 22,634 | 17,315 | 21,934 | Upgrade
|
| Operating Income | 2,347 | 2,034 | -12,738 | -15,280 | -3,859 | -9,291 | Upgrade
|
| Interest Expense | -2,270 | -2,002 | -2,206 | -1,380 | -1,145 | -2,045 | Upgrade
|
| Interest & Investment Income | 626.63 | 384.99 | 219.84 | 107.61 | 127.55 | 215.82 | Upgrade
|
| Earnings From Equity Investments | -300 | -1,172 | -1,199 | -556.16 | -420.88 | -227.95 | Upgrade
|
| Currency Exchange Gain (Loss) | 159.02 | 740.73 | 1,961 | 2,301 | -1,707 | 670.8 | Upgrade
|
| Other Non Operating Income (Expenses) | -186.2 | -330.56 | -2,027 | 4,630 | 639.47 | 3,235 | Upgrade
|
| EBT Excluding Unusual Items | 376.71 | -343.96 | -15,989 | -10,178 | -6,365 | -7,443 | Upgrade
|
| Gain (Loss) on Sale of Investments | 75.85 | 49.41 | - | 1,684 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -7,264 | 16.24 | -65.73 | 220.44 | -519.34 | -856.45 | Upgrade
|
| Asset Writedown | -16.8 | -16.8 | -243.71 | -623.87 | -2,355 | -5,540 | Upgrade
|
| Other Unusual Items | -143.59 | -6,173 | - | - | - | - | Upgrade
|
| Pretax Income | -6,972 | -6,468 | -16,299 | -8,897 | -9,239 | -13,839 | Upgrade
|
| Income Tax Expense | -1,690 | -1,229 | -65.76 | 4,749 | 1,433 | -2,266 | Upgrade
|
| Earnings From Continuing Operations | -5,281 | -5,239 | -16,233 | -13,646 | -10,672 | -11,573 | Upgrade
|
| Minority Interest in Earnings | 3,781 | 3,372 | 2,608 | 3,978 | -43.26 | 806.4 | Upgrade
|
| Net Income | -1,500 | -1,867 | -13,625 | -9,669 | -10,715 | -10,766 | Upgrade
|
| Net Income to Common | -1,500 | -1,867 | -13,625 | -9,669 | -10,715 | -10,766 | Upgrade
|
| Shares Outstanding (Basic) | 20 | 16 | 13 | 13 | 12 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 20 | 16 | 13 | 13 | 12 | 10 | Upgrade
|
| Shares Change (YoY) | 37.35% | 21.04% | 0.07% | 12.57% | 14.15% | 5.11% | Upgrade
|
| EPS (Basic) | -75.11 | -115.17 | -1017.14 | -722.29 | -901.11 | -1033.51 | Upgrade
|
| EPS (Diluted) | -75.11 | -115.17 | -1017.14 | -722.29 | -901.11 | -1034.00 | Upgrade
|
| Free Cash Flow | -11,965 | -3,417 | -6,684 | -10,501 | -2,721 | -575.28 | Upgrade
|
| Free Cash Flow Per Share | -599.05 | -210.77 | -498.99 | -784.49 | -228.82 | -55.22 | Upgrade
|
| Gross Margin | 86.36% | 85.87% | 74.83% | 47.84% | 69.52% | 47.58% | Upgrade
|
| Operating Margin | 7.07% | 6.80% | -64.44% | -99.40% | -19.94% | -34.96% | Upgrade
|
| Profit Margin | -4.52% | -6.24% | -68.93% | -62.89% | -55.36% | -40.51% | Upgrade
|
| Free Cash Flow Margin | -36.06% | -11.43% | -33.81% | -68.31% | -14.06% | -2.16% | Upgrade
|
| EBITDA | 5,131 | 4,347 | -10,436 | -13,555 | -770.01 | -5,811 | Upgrade
|
| EBITDA Margin | 15.46% | 14.54% | -52.80% | -88.18% | -3.98% | -21.87% | Upgrade
|
| D&A For EBITDA | 2,784 | 2,313 | 2,302 | 1,725 | 3,089 | 3,480 | Upgrade
|
| EBIT | 2,347 | 2,034 | -12,738 | -15,280 | -3,859 | -9,291 | Upgrade
|
| EBIT Margin | 7.07% | 6.80% | -64.44% | -99.40% | -19.94% | -34.96% | Upgrade
|
| Advertising Expenses | - | 130.35 | 176.7 | 178.07 | 68.79 | 348.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.